Lumbokinase
Lumbokinase attenuates myocardial ischemia-reperfusion (I-R) injury through the activation of Sirt1 signaling, and thus enhances autophagic flux and reduces I-R-induced oxidative damage, inflammation and apoptosis[1].
Product Specifications
CAS Number
556743-18-1
UNSPSC
12352204
Target
Sirtuin
Type
Enzyme
Related Pathways
Cell Cycle/DNA Damage; Epigenetics
Applications
COVID-19-anti-virus
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/lumbokinase-capsules.html
Solubility
H2O : ≥ 2 mg/mL
Smiles
[Lumbokinase]
References & Citations
[1]Wang YH, et, al. Sirt1 Activation by Post-ischemic Treatment With Lumbrokinase Protects Against Myocardial Ischemia-Reperfusion Injury. Front Pharmacol. 2018 Jun 15;9:636.
Shipping Conditions
Blue Ice
Storage Conditions
Store at -20°C for 2 years
Scientific Category
Enzyme
Clinical Information
No Development Reported
Isoform
SIRT1
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY401916 100 µg
Semaphorin 3c (SEMA3C) (NM_006379) Human Over-expression Lysate
Sign In for Pricing
View Details